GeneDx Holdings Corp. Other Operating Income (Expense), Net
GeneDx Holdings Corp. (WGS) reported Other Operating Income (Expense), Net of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2026-02-23
- GeneDx Holdings Corp. other operating income (expense), net for the quarter ending 2024-12-31 was $2.62M, a 20.59% decline year-over-year.
- GeneDx Holdings Corp. other operating income (expense), net for the quarter ending 2024-09-30 was -$774.00K.
- GeneDx Holdings Corp. other operating income (expense), net for the quarter ending 2024-06-30 was -$874.00K.
- GeneDx Holdings Corp. other operating income (expense), net for the quarter ending 2024-03-31 was -$974.00K.
- GeneDx Holdings Corp. other operating income (expense), net for fiscal 2025 was $0.00.
- GeneDx Holdings Corp. other operating income (expense), net for fiscal 2024 was $0.00.
- GeneDx Holdings Corp. other operating income (expense), net for fiscal 2023 was -$1.96M.
- GeneDx Holdings Corp. other operating income (expense), net for fiscal 2022 was -$6.31M.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 3 month as first filed | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 6 month as first filed | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month | Other Operating Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | ||||||
| 2024-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.85M derived: sum of 2 quarters · filed 2026-02-23 | $974.00K derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | -$3.41M 10-K · filed 2025-02-20 | ||
| 2024-09-30 | -$774.00K 10-Q · filed 2024-10-29 | -$1.65M derived: sum of 2 quarters · filed 2024-10-29 | -$2.62M 10-Q · filed 2024-10-29 | $680.00K derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | -$874.00K 10-Q · filed 2024-07-30 | -$1.85M 10-Q · filed 2024-07-30 | $1.45M derived: sum of 3 quarters · filed 2026-02-23 | -$1.34M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | -$974.00K 10-Q · filed 2024-04-29 | $2.33M derived: sum of 2 quarters · filed 2026-02-23 | -$466.00K derived: sum of 3 quarters · filed 2026-02-23 | -$1.18M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $508.00K derived: sum of 2 quarters · filed 2026-02-23 | -$210.00K derived: sum of 3 quarters · filed 2026-02-23 | -$1.96M 10-K · filed 2026-02-23 | -$7.22M 10-K · filed 2024-02-23 | ||
| 2023-09-30 | -$2.79M 10-Q · filed 2024-10-29 | -$3.51M derived: sum of 2 quarters · filed 2024-10-29 | -$5.26M 10-Q · filed 2024-10-29 | -$6.86M derived: sum of 4 quarters · filed 2024-10-29 | |||
| 2023-06-30 | -$718.00K 10-Q · filed 2024-07-30 | $334.00K 10-Q · filed 2023-08-08 | -$2.46M 10-Q · filed 2024-07-30 | $334.00K 10-Q · filed 2023-08-08 | -$4.07M derived: sum of 3 quarters · filed 2024-07-30 | -$5.76M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | -$1.75M 10-Q · filed 2024-04-29 | -$3.35M derived: sum of 2 quarters · filed 2024-04-29 | -$5.04M derived: sum of 3 quarters · filed 2024-04-29 | -$5.04M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$3.30M derived: sum of 2 quarters · filed 2024-02-23 | -$3.30M derived: sum of 3 quarters · filed 2024-02-23 | -$6.31M 10-K · filed 2024-02-23 | |||
| 2022-09-30 | -$1.70M 10-Q · filed 2023-11-03 | -$1.70M derived: sum of 2 quarters · filed 2023-11-03 | -$4.71M 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |